incruse ellipta
Generic: umeclidinium
Labeler: glaxosmithkline llcDrug Facts
Product Profile
Brand Name
incruse ellipta
Generic Name
umeclidinium
Labeler
glaxosmithkline llc
Dosage Form
AEROSOL, POWDER
Routes
Active Ingredients
umeclidinium bromide 62.5 ug/1
Manufacturer
Identifiers & Regulatory
Product NDC
0173-0873
Product ID
0173-0873_44e97b9b-e22d-4bef-a025-20e71b0b3966
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA205382
Listing Expiration
2026-12-31
Marketing Start
2014-04-30
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01730873
Hyphenated Format
0173-0873
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
incruse ellipta (source: ndc)
Generic Name
umeclidinium (source: ndc)
Application Number
NDA205382 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 62.5 ug/1
Packaging
- 1 TRAY in 1 CARTON (0173-0873-06) / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALER
- 1 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "44e97b9b-e22d-4bef-a025-20e71b0b3966", "openfda": {"unii": ["7AN603V4JV"], "rxcui": ["1539251", "1539885", "1596444", "1596445"], "spl_set_id": ["dbb64747-1505-49d7-9a33-99dd402e96d3"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (0173-0873-06) / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALER", "package_ndc": "0173-0873-06", "marketing_start_date": "20140430"}, {"sample": false, "description": "1 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER", "package_ndc": "0173-0873-10", "marketing_start_date": "20140430"}], "brand_name": "Incruse Ellipta", "product_id": "0173-0873_44e97b9b-e22d-4bef-a025-20e71b0b3966", "dosage_form": "AEROSOL, POWDER", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]"], "product_ndc": "0173-0873", "generic_name": "umeclidinium", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Incruse Ellipta", "active_ingredients": [{"name": "UMECLIDINIUM BROMIDE", "strength": "62.5 ug/1"}], "application_number": "NDA205382", "marketing_category": "NDA", "marketing_start_date": "20140430", "listing_expiration_date": "20261231"}